AVTX
Avalo Therapeutics·NASDAQ
--
--(--)
--
--(--)
AVTX Filings
Filing Date
Form Description
Form Type
2026-02-03
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-03 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-01-30
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-30 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-29
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-29 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-21
Form EFFECT - Notice of Effectiveness
2026-01-21 ·
Form EFFECT - Notice of Effectiveness
2026-01-12
Form 8-K - Current report
Key Events
2026-01-12 · Key Events
Form 8-K - Current report
2026-01-08
Form S-3 - Registration statement under Securities Act of 1933
2026-01-08 ·
Form S-3 - Registration statement under Securities Act of 1933
2026-01-05
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-05 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-05
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-05 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-12
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-12 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-12
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-12 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
